Update on T-Cell Lymphoma Epidemiology
Current Hematologic Malignancy Reports · 2024-06 · 19 (3) · 93-103
DOI: 10.1007/s11899-024-00727-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Hematologic Malignancy Reports, online erschienen am 07.03.2024. Verfasst von Jane J Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Warren Alpert Medical School of Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Lymphoma, T-Cell. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
PURPOSE OF REVIEW: T-cell lymphomas (TCLs) are a group of rare subtypes of non-Hodgkin lymphoma derived from mature T-lymphocytes. Recent updates in lymphoma classification based on the cell-of-origin pathogenesis have shed new light on TCL epidemiology and outcomes. Contemporary regional consortia and international studies, including those conducted recently in Asia and South America, have provided an updated delineation of the major subtypes across various global regions. RECENT FINDINGS: Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remains the most common subtype globally except in Asia, where extra-nodal NK-T cell lymphoma (ENKTL) has emerged as the most prevalent. Angioimmunoblastic T-cell lymphoma (AITL) is the second most common subtype globally except in South America where its incidence falls behind adult T-cell leukemia/lymphoma (ATLL) and ENKTL. ALK-negative anaplastic large cell lymphoma (ALCL) has been recognized as the second most common subtype in some parts of South America. Studies on the newly classified breast implant-associated ALCL (BIA-ALCL) are beginning to reveal its distribution and risk factors. Deciphering the epidemiology of TCLs is a challenging endeavor due to the rarity of these entities and ongoing refinement in classification. Collaborative efforts on prospective registries based on the most current WHO classifications will help capture the true epidemiology of TCL subtypes to better focus resources for diagnostic, prognostic, and therapeutic efforts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Warren Alpert Medical School of Brown University, Providence, RI, USA.
- Division of Hematology and Medical Oncology, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10065, USA.
- Division of Dermatology, Weill Cornell Medicine, New York, NY, USA.
- Division of Hematology and Medical Oncology, Weill Cornell Medicine, 1305 York Avenue, New York, NY, 10065, USA. jruan@med.cornell.edu.
Zitieren
APA
Chen, J. J., Tokumori, F. C., Del Guzzo, C., Kim, J., & Ruan, J. (2024). Update on T-Cell Lymphoma Epidemiology. Current Hematologic Malignancy Reports, 19(3), 93-103. https://doi.org/10.1007/s11899-024-00727-w
Vancouver
Chen JJ, Tokumori FC, Del Guzzo C, Kim J, Ruan J. Update on T-Cell Lymphoma Epidemiology. Current Hematologic Malignancy Reports. 2024;19(3):93-103. doi:10.1007/s11899-024-00727-w
BibTeX
@article{Chen2024,
author = {Chen, Jane J and Tokumori, Franco Castillo and Del Guzzo, Christina and Kim, Jeanyoung and Ruan, Jia},
title = {Update on T-Cell Lymphoma Epidemiology},
journal = {Current Hematologic Malignancy Reports},
year = {2024},
volume = {19},
number = {3},
pages = {93--103},
doi = {10.1007/s11899-024-00727-w}
}
EUVIMED